Search research articles
Contact Us
Filters
Showing results (271-280 of 332) with videos related to
Page
of 34
Sort By:
Journal of Neurointerventional Surgery
|
November 2, 2023
Susceptibility vessel sign, a predictor of long-term outcome in patients with stroke treated with mechanical thrombectomy
Morin Beyeler, Erich Rea, Loris Weber, et al.
Blood
|
February 26, 2025
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study
Joshua F Zeidner, David A Sallman, Christian Récher, et al.
Bone Marrow Transplantation
|
August 2, 2024
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT
Rama Al Hamed, Myriam Labopin, Depei Wu, et al.
Blood
|
July 19, 2013
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA
Richard F Schlenk, Erdogan Taskesen, Yvette van Norden, et al.
Frontiers in Neurology
|
April 6, 2023
Absence of susceptibility vessel sign and hyperdense vessel sign in patients with cancer-related stroke
Morin Beyeler, Lorenz Grunder, Jayan Göcmen, et al.
Frontiers in Neurology
|
October 2, 2025
Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer
Moritz C Kielkopf, Jayan Göcmen, Selina B Venzin, et al.
The Lancet. Haematology
|
November 1, 2023
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study
Thomas Pabst, Cristina Papayannidis, Fatih Demirkan, et al.
Blood Advances
|
February 24, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities
Emma L Boertjes, Tim Grob, Adil Al Hinai, et al.
Leukemia
|
June 15, 2026
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study
Simon Renders, Maud Ngoya, Laurence de Leval, et al.
Blood Advances
|
January 13, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities
Emma L Boertjes, Tim Grob, Adil Salim Abdullah Al Hinai, et al.
Page
of 34
Search research articles
Search
Showing results (271-280 of 332) with videos related to
Sort By:
Page
of 34
Journal of Neurointerventional Surgery
|
November 2, 2023
Susceptibility vessel sign, a predictor of long-term outcome in patients with stroke treated with mechanical thrombectomy
Morin Beyeler, Erich Rea, Loris Weber, et al.
Blood
|
February 26, 2025
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study
Joshua F Zeidner, David A Sallman, Christian Récher, et al.
Bone Marrow Transplantation
|
August 2, 2024
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT
Rama Al Hamed, Myriam Labopin, Depei Wu, et al.
Blood
|
July 19, 2013
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA
Richard F Schlenk, Erdogan Taskesen, Yvette van Norden, et al.
Frontiers in Neurology
|
April 6, 2023
Absence of susceptibility vessel sign and hyperdense vessel sign in patients with cancer-related stroke
Morin Beyeler, Lorenz Grunder, Jayan Göcmen, et al.
Frontiers in Neurology
|
October 2, 2025
Anticoagulant versus antiplatelet treatment for secondary stroke prevention in patients with active cancer
Moritz C Kielkopf, Jayan Göcmen, Selina B Venzin, et al.
The Lancet. Haematology
|
November 1, 2023
Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study
Thomas Pabst, Cristina Papayannidis, Fatih Demirkan, et al.
Blood Advances
|
February 24, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities
Emma L Boertjes, Tim Grob, Adil Al Hinai, et al.
Leukemia
|
June 15, 2026
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study
Simon Renders, Maud Ngoya, Laurence de Leval, et al.
Blood Advances
|
January 13, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities
Emma L Boertjes, Tim Grob, Adil Salim Abdullah Al Hinai, et al.
Page
of 34